Breast Density Notification Requirements, Testing Inconsistencies May Confuse Women, Review Suggests

Tuesday, January 19, 2016

HealthImaging (1/15, Pearson) reports, “Determination of breast density fluctuates considerably from one exam to the next in any given woman,” which “can both perplex the patient and drive unintended consequences into her care pathway – effects that may be exacerbated by the direct-to-consumer density notifications required by law in (so far) 24 U.S. states.” Additionally, investigators found that “supplemental screening of women with dense breasts does indeed find additional breast cancer, but it also increases false positives.” These findings come from a review published online in the Annals of Internal Medicine. 

Women’s Health Care Advocates Speak out Against USPSTF for Finalizing Guidelines Despite Legislation Imposing a Two-Year Moratorium on Their Implementation

Tuesday, January 12, 2016

A group of like-minded women’s health care organizations expressed their disappointment with the United States Preventive Services Task Force (USPSTF or Task Force) for finalizing its draft breast cancer screening recommendations in spite of 2015 legislation mandating a moratorium on implementation. The Task Force chose to publish its guidelines just weeks after Congress passed the legislation that would prevent the recommendations from going into effect until Jan. 1, 2018, adding another layer of confusion for women and physicians.

Radiologists Remain Scornful of USPSTF Mammo Guidelines

Tuesday, January 12, 2016

SBI Immediate Past President, Murray Rebner, MD, FSBI, SBI Board Member Jay Baker, MD, FSBI and SBI Members Rachel Brem, MD, FSBI, Avice O'Connell, MD, FSBI, Susan Harvey, MD, and Wendie Berg, MD, FSBI, warn that the final breast cancer screening guidelines, issued by the U.S. Preventive Services Task Force (USPSTF), will cause the deaths of thousands of women. 

Improvements In Breast Cancer Treatments Have Barely Changed Benefit Of Using Mammograms As Screening Tool, Study Suggests

Tuesday, January 12, 2016

The Los Angeles Times (1/12, Kaplan) “Science Now” reports that research suggests that with regard to “breast cancer, improvements in treatment have barely changed the benefit of using mammograms as a screening tool.” The research “explains that the value of early detection depends in part on the effectiveness of treatment.” The findings were published in Annals of Internal Medicine. 

USPSTF Releases Breast Cancer Screening Guidelines

Tuesday, January 12, 2016
The United States Preventative Services Task Force’s (USPSTF) new guidelines on breast cancer screening received extensive media coverage, with major US newspapers, websites, and wires covering the story. The guidelines were also discussed on two of last night’s national news broadcasts. Much of the coverage focused on the confusion surrounding screening, as several different groups have their own recommendations regarding screening. Coverage also focused on several medical groups’ criticisms of the recommendations.